Natasha Rekhtman Selected Research

Natasha Rekhtman Research Topics

Disease

57	Neoplasms (Cancer) 05/2024 - 10/2003
36	Lung Neoplasms (Lung Cancer) 05/2024 - 11/2012
23	Adenocarcinoma of Lung 01/2023 - 02/2013
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 03/2011
11	Adenocarcinoma 04/2024 - 06/2010
11	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 06/2010
10	Carcinoma (Carcinomatosis) 01/2022 - 06/2010
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 01/2016
6	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2019
4	Pneumonia (Pneumonitis) 12/2020 - 01/2017
3	Brain Neoplasms (Brain Tumor) 04/2024 - 06/2015
2	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2024
2	Necrosis 01/2023 - 01/2020
2	Acute Lung Injury 12/2022 - 12/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	Carcinogenesis 01/2022 - 01/2021
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021 - 01/2019
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 04/2008
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2019 - 01/2019
2	Small Cell Carcinoma 01/2019 - 06/2010
2	Carcinoid Tumor (Carcinoid) 01/2019 - 10/2010
2	Acute Erythroblastic Leukemia (Erythroleukemia) 11/2003 - 10/2003
1	Disease Progression 04/2024
1	Respiratory Insufficiency (Respiratory Failure) 12/2022
1	Arthritis (Polyarthritis) 10/2022
1	Residual Neoplasm 07/2021
1	Neoplasms, Cystic, Mucinous, and Serous 01/2021
1	Infections 01/2021
1	Adenoma (Adenomas) 01/2021
1	COVID-19 12/2020
1	Lung Injury 01/2020
1	Radiation Pneumonitis 01/2020

Drug/Important Bio-Agent (IBA)

10	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2015
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2012
8	ErbB Receptors (EGF Receptor)IBA 01/2022 - 02/2013
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2010
7	Immune Checkpoint InhibitorsIBA 07/2021 - 04/2015
7	B7-H1 AntigenIBA 07/2021 - 03/2017
6	xylometazoline (stas)IBA 05/2024 - 01/2017
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2013
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2013
4	Transcription Factors (Transcription Factor)IBA 04/2024 - 01/2020
4	osimertinibIBA 01/2023 - 01/2018
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 07/2013
4	Hematoxylin (Haematoxylon)IBA 01/2020 - 07/2013
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 11/2012
3	LigandsIBA 01/2024 - 04/2016
3	Thyroid Nuclear Factor 1IBA 01/2023 - 01/2017
3	Circulating Tumor DNAIBA 01/2023 - 07/2021
3	selpercatinibIBA 01/2022 - 01/2019
3	Anaplastic Lymphoma KinaseIBA 10/2016 - 11/2014
2	Messenger RNA (mRNA)IBA 04/2024 - 10/2010
2	SynaptophysinIBA 11/2023 - 01/2018
2	Cell-Free Nucleic AcidsIBA 01/2021 - 08/2016
2	CrizotinibIBA 01/2020 - 08/2015
2	Formaldehyde (Formol)FDA Link 10/2019 - 01/2019
2	ParaffinIBA 01/2019 - 06/2010
2	AntibodiesIBA 05/2018 - 04/2016
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 10/2013
2	cabozantinibIBA 12/2016 - 08/2015
1	AntigensIBA 04/2024
1	Surface Antigens (Surface Antigen)IBA 04/2024
1	AndrogensIBA 04/2024
1	Aligeron (AS 2)IBA 02/2024
1	Zirconium-89IBA 01/2024
1	Radioisotopes (Radionuclides)IBA 01/2024
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2024
1	S100 Proteins (S 100 Protein)IBA 11/2023
1	NAD (NADH)IBA 04/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2023
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 04/2023
1	3- (5- (4- (cyclopentyloxy)- 2- hydroxybenzoyl)- 2- ((3- hydroxy- 1,2- benzisoxazol- 6- yl)methoxy)phenyl)propionic acidIBA 10/2022
1	ChromatinIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	src-Family KinasesIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Colloids (Colloid)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	MTOR InhibitorsIBA 01/2021
1	pralsetinibIBA 01/2021
1	Viral ProteinsIBA 01/2021
1	Viral AntigensIBA 12/2020
1	Viral RNAIBA 12/2020
1	HemosiderinIBA 01/2020
1	Ki-67 Antigen (Ki 67 Antigen)IBA 10/2019
1	Cytidine DeaminaseIBA 10/2019
1	APOBEC-1 DeaminaseIBA 10/2019
1	Peptides (Polypeptides)IBA 10/2019
1	Co-Repressor ProteinsIBA 10/2019
1	Bortezomib (Velcade)FDA Link 01/2019

Therapy/Procedure

30	Therapeutics 04/2024 - 10/2003
8	Immunotherapy 01/2022 - 04/2016
4	Drug Therapy (Chemotherapy) 07/2021 - 10/2013
2	Aftercare (After-Treatment) 05/2018 - 06/2014
1	Artificial Respiration (Mechanical Ventilation) 12/2022
1	Precision Medicine 01/2021
1	Radiotherapy 01/2020
1	Chemoradiotherapy 01/2020